Dr. Scott C. Woller, MD
Claim this profileStudies Pulmonary Embolism
Studies Deep Vein Thrombosis
1 reported clinical trial
1 drug studied
Clinical Trials Scott C. Woller, MD is currently running
More about Scott C. Woller, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Scott C. Woller, MD has experience with
- Alerting Providers At Patient Hospital Discharge To Consider Prescribing Rivaroxaban To Reduce Venous Thromboembolism
Breakdown of trials Scott C. Woller, MD has run
Pulmonary Embolism
Deep Vein Thrombosis
Blood Clot
Hospital Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott C. Woller, MD specialize in?
Scott C. Woller, MD focuses on Pulmonary Embolism and Deep Vein Thrombosis. In particular, much of their work with Pulmonary Embolism has involved treating patients, or patients who are undergoing treatment.
Is Scott C. Woller, MD currently recruiting for clinical trials?
Yes, Scott C. Woller, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Scott C. Woller, MD has studied deeply?
Yes, Scott C. Woller, MD has studied treatments such as Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism.
What is the best way to schedule an appointment with Scott C. Woller, MD?
Apply for one of the trials that Scott C. Woller, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.